Pellets were then resuspended in FACS buffer and incubated with Cd45-FITC (rat IgG2b), Cd45-Brillant Violet 570 (rat IgG2b,), Cd11b-APC (rat IgG2b,), Cd11b-(Mac1)-PERCy5.5 (rat IgG2b,), F4/80-PECy7 (rat IgG2a,), Ly6g-APC-Cy7 (rat IgG2a,), Cd11c-PE (hamster IgG), Cd11c-APC (hamster IgG), Cd206-FITC (rat IgG2a,), Cd3-PECy7 (hamster IgG), SiglecF-PCy7 (rat IgG2a,), NK1.1-APC (mouse IgG2a,), Cd8-Brilliant Violet 421 (rat IgG2a,), Cd4-PERCy5.5 (rat IgG2b,), TCR-FITC (hamster IgG) and IL4-PE (rat IgG1) antibodies (Supplementary Data 1) or their corresponding isotype controls for 20 min at RT
Whether your medication remains safe to use depends on specific factors including ambient temperature, exposure duration, and cumulative room temperature storage time
Decide, together with your prescribing clinician, whether holding a dose is appropriate in your particular situation
actual products may vary